STEPHEN KELLY: Open Payments
NPI 1134167455 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,515 in 80 payments from 21 companies in 2025. Trend: 2023 $1,848 · 2024 $1,462 · 2025 $1,515
Food & beverage: $1,515
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $333 |
| Forte Bio-Pharma LLC | 13 | $206 |
| Teva Pharmaceuticals USA, Inc. | 5 | $122 |
| ABBVIE INC. | 6 | $111 |
| PROTEGA PHARMACEUTIALS INC | 5 | $101 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Lundbeck LLC | 3 | $77 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $62 |
| Valinor Pharma, LLC | 3 | $54 |
| PFIZER INC. | 3 | $53 |
Products named: RELISTOR, PROLATE, AJOVY, UBRELVY, ROXYBOND, REXULTI, VYEPTI, JOURNAVX.
Industry payments across OK — which companies pay providers there.
